. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Radiology. 2014 Oct 10;274(3):917–926. doi: 10.1148/radiol.14141308

Table 2.

Clinical Trial Participant Demographics

Patient No./Age(y)/Sex	Liver Disease	Prior Surgery	Prior Chemotherapy	Laboratory Values			Target Lesion Size (mm)
Patient No./Age(y)/Sex	Liver Disease	Prior Surgery	Prior Chemotherapy	Total Bilirubin (mg/dL)^*	AST (U/L)^†	ALT (U/L)^†	Target Lesion Size (mm)
1/55/M	None	None	None	0.6	33	52	13
2/67/M	HCV cirrhosis, Child-Pugh class A5	None	None	0.4	175	249	21
3/62/M	HCV, alcoholic cirrhosis; Child-Pugh class A6	None	None	0.6	53	18	15, ablation
3/62/M	HCV, alcoholic cirrhosis; Child-Pugh class A6	None	None	0.6	53	18	18, biopsy
4/73/M	Hemochromatosis cirrhosis, Child-Pugh class A5	None	None	0.5	44	49	10
5/66/M	None	Partial colectomy	None	0.6	19	14	17

Note.—ALT = alanine aminotransferase, AST = aspartate aminotransferase, HCV = hepatitis C virus.

To convert to Système International units in micromoles per liter, multiply by 17.104.

^†

To convert to Système International units in microkatals per liter, multiply by 0.0167.